Latest Share Consolidation News

Talius Group Limited has secured shareholder approval to consolidate its shares on a 10-for-1 basis, aiming to better align its capital structure with industry peers. The move affects all ordinary shares and performance rights, effective June 4, 2025.

Adavale Resources plans a significant 20:1 share consolidation to streamline its capital structure and attract institutional investors, coinciding with promising exploration progress at its Parkes Gold and Copper Project.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Trinex Minerals is set to seek shareholder approval for a significant 127:1 share consolidation aimed at streamlining its capital structure and enhancing investor appeal. The move also adjusts options and performance rights accordingly.

Orbminco Limited has entered a binding agreement to acquire the Majestic North Gold Project in Western Australia, boasting a JORC-compliant resource of nearly 40,000 ounces of gold. The company is raising A$0.88 million to support due diligence and exploration activities.

Trinex Minerals announces a A$1 million two-tranche capital raising, including director participation and plans for a potential share consolidation.

Codeifai Limited has released an updated timetable for its capital consolidation, outlining key dates from shareholder approval to the commencement of post-consolidation trading.

88 Energy Limited has secured shareholder approval for a significant capital consolidation, reducing its share count by a factor of 25 effective May 9, 2025. The company has outlined a detailed timetable to guide investors through the transition.

Assetora Limited has dramatically reduced its net liabilities and strengthened its balance sheet through strategic capital raises and debt conversions, while unveiling a comprehensive rebrand and leadership expansion to drive its next growth phase.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Antipa Minerals has consolidated its Paterson Province tenements into the expansive Minyari Project, resumed full ownership of Wilki and Paterson Projects following partner withdrawals, and launched a major drilling campaign targeting resource growth and new discoveries.